Such a shame that the Hough pill could have been in Phase 3 by now or released in the market. They finished Phase 1 in 2015, like really, it took them 5 years to get more funding, it is unbelievable.
Yeah, we need more companies like Astella (the company funding FX-322). Their business model is really unique. The following is my understanding of it...
They front the money to biotech labs (in this case Frequency Therapeutics) for promising therapies to go through trials in exchange for licensing the product and taking a percentage of the profits, once it hits the market.
The biotech labs get to keep their independence and have control of the daily operations during trials. This means the original people who are passionate about the given therapy continue to work closely on it.
This is way better than biotech labs either
1.) Being bought out entirely by a big pharmaceutical company (who may shelf the therapy for years or abandon it entirely depending on their business strategy).
2.) Left to their own devices to find investors willing to give hundreds of millions.
The fact that any new drug needs to go through FDA trials (there is no alternative for vetting) before selling their drug on the market legally creates quite the obstacle for small to medium-sized biotech labs that don't have the required funding. Companies like Astella help build a bridge over that obstacle.
I'm not sure what happened to make the Hough Pill sit idle for 5 years, but I suspect it happens frequently with all sorts of new drugs that could be helping people with all sorts of ailments by now.
I will hold my tongue as far as criticizing the FDA/gov't to avoid having this thread go off-topic again.